Regenerative Medical Technology Group Inc.
Cash Flow Statement
| Line Item | FY2017 |
|---|---|
| Operating Activities | |
| Net Income | $-377.0K |
| Depreciation & Amortization | — |
| Depreciation | — |
| Amortization | — |
| Stock-Based Compensation | — |
| Net Cash from Operating Activities | $-6.1K |
| Investing Activities | |
| Capital Expenditures | — |
| Business Acquisitions | — |
| Net Cash from Investing Activities | $5 |
| Financing Activities | |
| Dividends Paid | — |
| Stock Repurchases | — |
| Net Cash from Financing Activities | $7.2K |
| Net Change in Cash | $1.1K |
| Free Cash Flow | — |